Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enwave Corp NWVCF


Primary Symbol: V.ENW

EnWave Corporation is an applied dehydration technology company. The Company’s principal business is the licensing of its intellectual property through royalty-bearing agreements and the design, construction, marketing, and sales of vacuum-microwave dehydration machinery for the food, cannabis and biomaterial industries. It has entered into 54 royalty-bearing commercial licenses with and sold REV equipment to a diverse portfolio of companies operating in over 23 different countries on five continents. It also operates REVworx, a toll processing facility located in Delta, British Columbia that offers vacuum-microwave contract manufacturing services. The REVworx facility houses both a batch 10 kilowatt (kW) and 60 kW continuous vacuum-microwave line to accelerate the commercialization of products made with the Company’s patented technology. The Company has two primary commercial scale technologies, nutraREV, a drum-based system, and quantaREV, a tray-based system.


TSXV:ENW - Post by User

Comment by Possibleidiot01on Aug 23, 2024 9:06am
117 Views
Post# 36193110

RE:RE:RE:RE:Time for ENWAVE to put a dividend program into place.

RE:RE:RE:RE:Time for ENWAVE to put a dividend program into place.No profit to share.

EnWave Corporation
Condensed Consolidated Interim Statements of Loss
For the three and nine months ended June 30, 2024 and 2023
(Unaudited, expressed in thousands of Canadian dollars, except per share data)
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
Three months ended Nine months ended
Note June 30,
2024
$
June 30,
2023
$
June 30,
2024
$
June 30,
2023
$
Revenues 15 2,622 2,486 4,547 9,906
Direct costs 1,471 1,767 3,330 5,894
1,151 719 1,217 4,012
Expenses
General and administration 664 501 1,740 1,753
Sales and marketing 358 277 1,149 1,167
Research and development 342 408 1,127 1,220
Stock-based compensation 13(c) 32 103 218 468
Impairment of assets - 315 - 315
Amortization of intangible assets 1 1 2 10
Finance income (42) (53) (148) (132)
Finance expense 40 31 103 99
Foreign exchange (gain)loss (9) 54 (36) 86
1,386 1,637 4,155 4,986
Loss from continuing operations before
income taxes (235) (918) (2,938) (974)
Income tax expense
Current - - - -
Deferred - - - -
Loss from continuing operations (235) (918) (2,938) (974)
Loss from discontinued operations 18 (32) (1,031) (35) (5,703)
Loss for the period (267) (1,949) (2,973) (6,677)
Net (loss)income per share:
Continuing operations, basic and diluted 0.00 (0.01) (0.02) (0.01)
Discontinued operations, basic and diluted 0.00 (0.01) 0.00 (0.05)
0.00 (0.02) (0.02) (0.06)
Weighted average number of common share

<< Previous
Bullboard Posts
Next >>